Genmab — Maj 2021
-
Skal vi ikke snart til at se noget epco-commitment fra AbbVie? Der var noget med udrulning af nogle fase 3 programmer…
-
God morgen.
-
Torsdagens aviser med SAS, KBHL og
ECBhttps://www.proinvestor.com/investornyt/675429/torsdagens-aviser-med-sas-kbhl-og-ecb -
God morgen
-
Lyt denne uge med om en positiv
opbremsning i Genmabs aktiekurs, hvorvidt kryptovalutaer er faldet til ro og om Norwegian taber flyvehøjde? Få også et bud på, om der er mere i vente efter det store comeback for danske aktier og en status på de seneste små danske selskabers børsentre. Det og meget mere i afsnit 67 af #Investeringspodcasten med Hansen og Larsen. https://www.youtube.com/watch?v=I8ibjBVtRwk&t=20s -
Det var en ny mand som skulle lave overskriften.Jeg får den lavet om.
-
Nohope...Lyder jeg som en sur negativ shorter i podcasten.
-
Oversigt med links til ProInvestors 22 nye FB-grupper https://www.proinvestor.com/index.php?p=debat_1&postid=93825
-
Pæn omsætning i luk....
-
God morgen.
-
Asien: Stigninger på baggrund af optimisme og teknisk omlægning https://www.proinvestor.com/investornyt/675481/asien-stigninger-pa-baggrund-af-optimisme-og-teknisk-omlaegning-ny
-
Fredagens aviser med SAS, Matas og Novo Nordiskhttps://www.proinvestor.com/investornyt/675476/fredagens-aviser-med-sas-matas-og-novo-nordisk
-
indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 (L858R) mutations. https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/tagrisso-approved-in-eu-in-early-lung-cancer.html
-
did we know this: KCR Cap
@KcrCap$HALO has patent protection on ENHANZE through 2024 in Europe and 2027 in the US. Royalty rates drop by 50% upon patent expiration, but royalties can still be collected for 10 years following commercial launch https://twitter.com/KcrCap/status/1398041938645995520
-
Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.17565
-
this is in Korean, from the Prof who will present on amivantamab at ASCO http://www.dreamdrug.com/Users/News/NewsView.html?ID=276681
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind